Skip to main content

Table 1 Patient characteristics

From: Impaired mitochondrial β-oxidation in patients with chronic hepatitis C: relation with viral load and insulin resistance

 

Patients

Reference value

Age (yr) b

54.2 ± 10.6

 

Male/Female (ratio)

14/16 (0.47)

 

BMI (kg/m2) b

23.7 ± 2.7

18.5 - 25

ALT (IU/L) a

47.5 (17–167)

8 - 42

γGTP (IU/L) a

41 (13–152)

10 - 47

ChE (IU/L) b

312.9 ± 88.2

185 - 431

Fasting plasma glucose (mg/dL) b

95.5 ± 9.7

70 - 109

Insulin (μIU/mL) a

8.7 (4.5 - 20.4)

1.84 - 12.2

HOMA-IR a

2.0 (1.2 - 5.1)

 

HOMA-IR > 2.5 (%)

9 (30)

 

Triglyceride (mg/dL) b

91.4 ± 31.1

30 - 149

Total cholesterol (mg/dL) b

175.2 ± 25.4

129 - 219

Acylcarnitine (μmol/L) a

9.25 (5.7 - 21.1)

6 - 23

HCV RNA (LogIU/mL) b

6.1 ± 0.9

 

HCV core antigen (fmol/L) a

6505 (<20–23200)

 

HCV Genotype

1b / 2a / 2b

20 / 6 / 4

 

Inflammation

A0 / A1 / A2 / A3

0 / 15 / 10 / 0

 

Fibrosis

F0 / F1 / F2 / F3 / F4

0 / 15 / 7 / 3 / 0

 

Steatosis

G0 / G1 / G2 / G3

6 /18 / 1 / 0

 
  1. BMI, body mass index; ALT, alanine aminotransferase; γGTP, gamma-glutamyltranspeptidase; ChE, cholinesterase; HOMA-IR, homeostasis model assessment of insulin resistance.
  2. Data are amedians (min-max), bthe means ± standard deviation.